How will pharma use health data for clinical trials in the future? The power of clinical trial tokenisation On 25 October 2022 leading researchers and executives from some of the world’s pioneering drug and pharmaceutical companies came together at a Financial Times Live Webinar event to discuss “The Power of Clinical Trial Tokenisation”. Tokenisation of healthcare data is likely to be one of the next great innovations for developing life-saving drugs and treatments through the…
Numerous data privacy and security laws govern the private sector’s collection and use of health data in the USA. These laws vary in scope and substance but some combination of them would probably apply to your company if, for example, it does any of the following in the country: Diagnoses or treats patients’ health conditions;Offers an app intended to promote the health or wellness of consumers;Provides health insurance or helps to process health insurance claims;Collects…
Synthetic datasets could change the way developers train AI models in healthcare. They have the potential to increase the size of training datasets for AI models, whilst protecting patient privacy, but is this really a solution or just hype? We’ve set out 7 things you need to know. 1. What is synthetic data? A synthetic dataset is an “artificial” dataset containing computer-generated data instead of real-word records. In the healthcare setting, the term “synthetic data” is…
On 10 March 2022, the National Data Management Office (NDMO) published for consultation a draft of the executive regulations (“Regulations”) to the Personal Data Protection Law, promulgated by Royal Decree No. M/19, dated 09/02/1443H (PDPL). You can access our previous alert on the publication of the Law here. You can access the consultation and a full draft of the Regulations here. The consultation invites comments on the Regulations and will close on 25 March 2022. The timing…
The NHS’s New Data Sharing Agreement NHSX has published a new Data Sharing Agreement (DSA) template. The template is a great tool for companies collaborating with NHS organisations to access and use data for R&D, and for companies which access and use data as part of their provision of services to the NHS. We’ve set out our top 5 takeaways below: What’s in a name? Data Sharing Agreement is a misnomer – this is not…
In this episode of Connect On Tech, your host Brian Hengesbaugh is joined by Ben McLaughlin, Global Chair of Baker McKenzie’s Healthcare & Life Sciences Group. Together Brian and Ben discuss healthcare data in the context of mergers and acquisitions. You will hear: An outline of the major players and issues surrounding acquisition of healthcare data.The number one issue keeping healthcare GCs up at night.Details on regulatory restrictions emerging to protect healthcare data. https://open.spotify.com/episode/51ImY8zLWMKH2IWr2z2PCU Related…
A new report provides a bold roadmap for the NHS to maximise the impact of its health data. The report, titled NHS data: Maximising its impact on the health and wealth of the United Kingdom, advocates for the UK government to take action now, before the UK is leapfrogged by other countries in health innovation. The report (available here) is from Imperial College London’s Institute of Global Health Innovation. The report examines some of the…